Can Thyroid Functions Be a Predictive Factor in Patients with Bronchopulmonary Dysplasia? A Single-Center Case-Control Study
Öz
Objective: Bronchopulmonary dysplasia (BPD) is a common pulmonary complication in preterm infants. Despite advances in neonatal care and improved survival rates, BPD remains a major cause of morbidity. This study aimed to evaluate the relationship between BPD and early thyroid function.
Materials and Methods: This retrospective case-control study included infants with a gestational age of <37 weeks who were hospitalized for ≥28 days between January 2022 and December 2023. Demographic and clinical data, together with thyroid function tests (TFTs) obtained during the first weeks of life, were analyzed. Patients were divided into BPD and non-BPD groups for comparison.
Results: A total of 172 infants were included, of whom 73 had BPD and 99 did not. Culture-proven sepsis (61.6% vs. 19.2%, p<0.001) and hemodynamically significant patent ductus arteriosus (hPDA) (37% vs. 6.1%, p<0.001) were more common in BPD patients. Thyroid-stimulating hormone (TSH) levels were significantly higher in the BPD group (8.66±17.34 vs. 3.41±2.13 mIU/L, p=0.001), whereas mean T4 levels were slightly lower (14.66±6.40 vs. 16.04±4.22 pmol/L), without statistical significance. Only three BPD patients were diagnosed with overt hypothyroidism.
Conclusion: Although TSH levels was higher in BPD infants, most values remained within the normal range, and overt hypothyroidism was rare. These findings suggest that early alterations in TFT may reflect physiological adaptation rather than clinically significant thyroid dysfunction. Therefore, thyroid function parameters have limited utility as predictors of BPD. Further prospective, multicenter studies are needed to clarify this relationship.
Anahtar Kelimeler
Etik Beyan
Kaynakça
- Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967;276:357-68.
- Bulbul A, Bacak T, Avsar H. Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia. Sisli Etfal Hastan Tip Bul 2023;52:171-81.
- Bose C, Marter LJ, Laughon M, O'Shea TM, Allred EN, Karna P, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009;124:e450-8.
- Morrow LA, Wagner BD, Ingram DA, Pointdexter BB, Schibler K, Cotton CM, et al. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants. Am J Respir Care Med 2017;196:364-74.
- Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, et al. Familial and genetic susceptibility to majör neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-6.
- Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert V, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 2018;197:300-8.
- Cloonan SM, Choi AMK. Mitochondria in lung disease. J Clin Invest. 2016;126:809-20.
- Bueno M, Lai YC, Romero Y, Brands J, Croix CMS, Kamga C, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest 2015;125:521-38.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Yenidoğan
Bölüm
Araştırma Makalesi
Yazarlar
Halil Dolap
0000-0003-2808-3533
Türkiye
Osman Kösek
0000-0002-8067-8967
Türkiye
Zehra Arslan
0000-0002-1939-405X
Türkiye
Erken Görünüm Tarihi
13 Kasım 2026
Yayımlanma Tarihi
-
Gönderilme Tarihi
17 Mart 2026
Kabul Tarihi
18 Ağustos 2026
Yayımlandığı Sayı
Yıl 2026 Sayı: Advanced Online Publication